GHG Emissions, Industrial, Sourcing Renewables  -  December 16, 2020

Bristol Myers Squibb sets target for 100% RE by 2030, carbon neutrality by 2040

Bristol Myers Squibb announced Dec. 16 its new sustainability targets, including a goal to source 100% renewable electricity by 2040 and be carbon neutral in Scope 1 and 2 emissions by 2040.

The biopharmaceutical company is also working toward a goal of using 100% electric vehicles in its fleet by 2040. Bristol Myers Squibb has previously pursued a policy of using sustainability to drive innovation, build resiliency and manage non-financial risk across its operations and portfolio.

Bristol Myers Squibb has been a signatory of the UN Global Compact for more than a decade and has been reporting its progress in alignment with the Global Reporting Initiative (GRI) framework since 2010. The next steps for the company will be setting approved science-based emissions reductions targets in alignment with the SBTi to deliver on its environmental commitments.

“As a leading global biopharma company dedicated to transforming patients’ lives through science, we understand our responsibility to create maximum positive impact while minimizing our environmental footprint,” Danielle Menture, vice president of Sustainability, EHS and Occupational Health, said in a statement. “Now, after 20 years of setting global sustainability goals, we are honing our focus to continue to reduce our energy consumption and greenhouse gas (GHG) emissions, improve water use and reduce waste. Along with announcing these goals, we commit to increased transparency in reporting our progress to internal and external stakeholders.”